Clinical Trial Update: Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy

View source ↗

Summary

This clinical trial update notes that a study evaluating adherence, persistence and efficacy of PCSK9 inhibitors for hypercholesterolemia in Italy is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• LEQVIO (inclisiran)
• Praluent (alirocumab)
• Repatha (Evolocumab)

Snippet

Sponsor: Federico II University | Conditions: Hypercholesterolemia | Status: RECRUITING